$2.49
-0.09-3.49%
At Close: -
$2.63
0.145.62%
After Hours: 9:28 AM EDT
15 minutes delayed
Comments
Loading...
Checkpoint Therapeutics
CKPTNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Checkpoint Therapeutics (NASDAQ:CKPT) Stock, Analyst Ratings, Price Targets, Forecasts
Checkpoint Therapeutics Inc has a consensus price target of $30.33 based on the ratings of 6 analysts. The high is $69 issued by Ladenburg Thalmann on April 3, 2023. The low is $4 issued by B. Riley Securities on December 20, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on July 16, 2024, June 24, 2024, and May 16, 2024, respectively. With an average price target of $34 between HC Wainwright & Co., there's an implied 1192.78% upside for Checkpoint Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
B. Riley Securities
Lake Street
Cantor Fitzgerald
Ladenburg Thalmann
1calculated from analyst ratings
Analyst Ratings for Checkpoint Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/16/2024 | Buy Now | 1192.78% | HC Wainwright & Co. | Joseph Pantginis | $34 → $34 | Reiterates | Buy → Buy | Get Alert |
| 06/24/2024 | Buy Now | 1192.78% | HC Wainwright & Co. | Joseph Pantginis | $34 → $34 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2024 | Buy Now | 1192.78% | HC Wainwright & Co. | Joseph Pantginis | → $34 | Reiterates | Buy → Buy | Get Alert |
| 03/22/2024 | Buy Now | 1192.78% | HC Wainwright & Co. | Joseph Pantginis | → $34 | Reiterates | Buy → Buy | Get Alert |
| 12/20/2023 | Buy Now | 52.09% | B. Riley Securities | Mayank Mamtani | $8 → $4 | Maintains | Buy | Get Alert |
| 12/19/2023 | Buy Now | 1192.78% | HC Wainwright & Co. | Joseph Pantginis | → $34 | Reiterates | Buy → Buy | Get Alert |
| 08/16/2023 | Buy Now | 432.32% | Lake Street | Thomas Flaten | $16 → $14 | Maintains | Buy | Get Alert |
| 08/15/2023 | Buy Now | 432.32% | Cantor Fitzgerald | Jennifer Kim | $19 → $14 | Maintains | Overweight | Get Alert |
| 08/15/2023 | Buy Now | 1687.07% | Ladenburg Thalmann | Jeffrey Cohen | $65 → $47 | Maintains | Buy | Get Alert |
| 08/04/2023 | Buy Now | 1192.78% | HC Wainwright & Co. | Joseph Pantginis | → $34 | Reiterates | Buy → Buy | Get Alert |
| 05/30/2023 | Buy Now | 508.37% | Lake Street | Thomas Flaten | $22 → $16 | Maintains | Buy | Get Alert |
| 05/17/2023 | Buy Now | 2371.48% | Ladenburg Thalmann | Jeffrey Cohen | $69 → $65 | Maintains | Buy | Get Alert |
| 05/16/2023 | Buy Now | 622.43% | Cantor Fitzgerald | Jennifer Kim | $54 → $19 | Maintains | Overweight | Get Alert |
| 04/28/2023 | Buy Now | 1192.78% | HC Wainwright & Co. | Joseph Pantginis | $76 → $34 | Maintains | Buy | Get Alert |
| 04/04/2023 | Buy Now | 736.5% | Lake Street | Thomas Flaten | $32 → $22 | Maintains | Buy | Get Alert |
| 04/03/2023 | Buy Now | 2523.57% | Ladenburg Thalmann | — | $96 → $69 | Maintains | Buy | Get Alert |
| 03/02/2023 | Buy Now | 2789.73% | HC Wainwright & Co. | Joseph Pantginis | → $76 | Reiterates | → Buy | Get Alert |
| 01/04/2023 | Buy Now | 470.34% | Cantor Fitzgerald | Jennifer Kim | → $15 | Maintains | Overweight | Get Alert |
| 12/23/2022 | Buy Now | 2789.73% | HC Wainwright & Co. | Joseph Pantginis | $26 → $76 | Maintains | Buy | Get Alert |
| 12/19/2022 | Buy Now | 470.34% | B. Riley Securities | Mayank Mamtani | $7 → $15 | Maintains | Buy | Get Alert |
| 01/25/2022 | Buy Now | 888.59% | HC Wainwright & Co. | Joseph Pantginis | $170 → $260 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Checkpoint Therapeutics (CKPT) stock?
The latest price target for Checkpoint Therapeutics (NASDAQ:CKPT) was reported by HC Wainwright & Co. on July 16, 2024. The analyst firm set a price target for $34.00 expecting CKPT to rise to within 12 months (a possible 1192.78% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Checkpoint Therapeutics (CKPT)?
The latest analyst rating for Checkpoint Therapeutics (NASDAQ:CKPT) was provided by HC Wainwright & Co., and Checkpoint Therapeutics reiterated their buy rating.
When was the last upgrade for Checkpoint Therapeutics (CKPT)?
There is no last upgrade for Checkpoint Therapeutics
When was the last downgrade for Checkpoint Therapeutics (CKPT)?
There is no last downgrade for Checkpoint Therapeutics.
When is the next analyst rating going to be posted or updated for Checkpoint Therapeutics (CKPT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Checkpoint Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Checkpoint Therapeutics was filed on July 16, 2024 so you should expect the next rating to be made available sometime around July 16, 2025.
Is the Analyst Rating Checkpoint Therapeutics (CKPT) correct?
While ratings are subjective and will change, the latest Checkpoint Therapeutics (CKPT) rating was a reiterated with a price target of $34.00 to $34.00. The current price Checkpoint Therapeutics (CKPT) is trading at is $2.63, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.